RemSleep Holdings (RMSL) Return on Capital Employed (2011 - 2025)
RemSleep Holdings recorded quarterly Return on Capital Employed of 2706.35% in Q4 2025, down 198.32% quarter-over-quarter from 907.21% in Q3 2025, and down 252839.0% year-over-year from N/an in Q4 2024.
RemSleep Holdings' Return on Capital Employed history runs 12 years deep, the most recent figure standing at 2706.35% for Q4 2025.
- In Q4 2025, Return on Capital Employed fell 252839.0% year-over-year to 2706.35%; the TTM figure through Dec 2025 stood at 2706.35% (down 252839.0% YoY), while the FY2025 annual figure was 1666.47%, down 154325.0% from the prior year.
- Return on Capital Employed came in at 2706.35% for Q4 2025 at RemSleep Holdings, down from 907.21% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 18.74% in Q2 2022 to a low of 2706.35% in Q4 2025.
- A 5-year average of 347.29% and a median of 147.84% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 1924 bps in 2022 and slumped 252839 bps in 2025, its largest moves.
- RemSleep Holdings' Return on Capital Employed stood at 20.15% in 2021, then slumped by 95 bps to 39.4% in 2022, then slumped by 199 bps to 117.71% in 2023, then sank by 51 bps to 177.96% in 2024, then slumped by 1421 bps to 2706.35% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 2706.35%, 907.21%, and 338.62% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | -2,706.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,706.35% |
| Sep 30, 2025 | -907.21% |
| Jun 30, 2025 | -338.62% |
| Mar 31, 2025 | -327.19% |
| Dec 31, 2024 | -177.96% |
| Sep 30, 2024 | -219.64% |
| Jun 30, 2024 | -282.73% |
| Mar 31, 2024 | -233.79% |
| Dec 31, 2023 | -117.71% |
| Sep 30, 2023 | -50.75% |
| Jun 30, 2023 | -44.66% |
| Mar 31, 2023 | -45.52% |
| Dec 31, 2022 | -39.40% |
| Sep 30, 2022 | -26.23% |
| Jun 30, 2022 | -18.74% |
| Dec 31, 2021 | -20.15% |
| Sep 30, 2019 | 214.96% |
| Jun 30, 2019 | 172.12% |
| Mar 31, 2019 | 17.38% |
| Dec 31, 2018 | 52.01% |
| Dec 31, 2016 | 66.52% |
| Dec 31, 2015 | 29.31% |
| Sep 30, 2013 | 44.19% |
| Jun 30, 2013 | 61.77% |
| Mar 31, 2013 | 172.98% |
| Dec 31, 2012 | 196.52% |
| Sep 30, 2012 | 128.51% |
| Jun 30, 2012 | 1,419.79% |
| Mar 31, 2012 | 3,036.12% |
| Sep 30, 2011 | 926,722.00% |